MedPath

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00002415
Lead Sponsor
Gilead Sciences
Brief Summary

The purpose of this study is to see if it is safe and effective to add PMPA Prodrug (a new anti-HIV drug) to an anti-HIV drug combination taken by patients who have taken anti-HIV drugs in the past. Genetic response will be studied.

Detailed Description

Prior to study entry patients are stratified according to HIV-1 RNA level, CD4 cell count, and number of antiretroviral drugs. PMPA Prodrug or placebo is added to current antiretroviral regimens, and is administered in one of three dosing regimens. Patients randomized to receive placebo are eligible to receive open-label PMPA Prodrug for the remainder of the 48-week study period after at least 24 weeks post randomization.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
175
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (24)

Harbor UCLA Med Ctr

🇺🇸

Torrance, California, United States

Hershey Med Ctr

🇺🇸

Hershey, Pennsylvania, United States

San Francisco Veterans Adm Med Cntr

🇺🇸

San Francisco, California, United States

The Research and Education Group

🇺🇸

Portland, Oregon, United States

East Bay AIDS Ctr

🇺🇸

Berkeley, California, United States

McDowell Clinic

🇺🇸

Phoenix, Arizona, United States

Univ of Colorado Health Sciences Ctr

🇺🇸

Denver, Colorado, United States

Amelia Ct Clinic

🇺🇸

Dallas, Texas, United States

Beth Israel Med Ctr

🇺🇸

New York, New York, United States

Cornell Clinical Trials Unit - Chelsea Clinic

🇺🇸

New York, New York, United States

CRI New England

🇺🇸

Brookline, Massachusetts, United States

Univ of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

UCSD Treatment Ctr

🇺🇸

San Diego, California, United States

Tower Infectious Disease Med Ctr

🇺🇸

Los Angeles, California, United States

AIDS Research Consortium of Atlanta Inc

🇺🇸

Atlanta, Georgia, United States

Grady Mem Hosp

🇺🇸

Atlanta, Georgia, United States

Univ Hosps of Cleveland

🇺🇸

Cleveland, Ohio, United States

Private Practice / Thacker and Thompson

🇺🇸

Atlanta, Georgia, United States

Northstar Med Clinic

🇺🇸

Chicago, Illinois, United States

Anderson Clinical Research

🇺🇸

Pittsburgh, Pennsylvania, United States

Thomas Street Clinic

🇺🇸

Houston, Texas, United States

Univ of Alabama at Birmingham / 1917 Rsch Cln

🇺🇸

Birmingham, Alabama, United States

Hillsborough County Health Dept Special Care Ctr

🇺🇸

Tampa, Florida, United States

Roger Williams Med Ctr

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath